Sunday, November 15, 2026

Peer-Reviewed Clinical Evidence Platform

The research that matters, without the jargon.

Peer-reviewed breakthroughs in plain English alongside verified outcomes, evidence grades, and clinical study details for everyone from everyday readers to medical students.

ClearMed Editorial Digest500 briefings across 12 specialties121 Phase III & clinical practice

Indexed from PubMed, NEJM, The Lancet, JAMA, Nature MedicineSaved Library

Health Hubs:

Stage: Evidence:

Showing 13 briefings matching “inflammation”

Reset all filters

Neurology

Neurology Clinical Briefings

Peer-Reviewed Clinical Digests · Verified Scientific Media

NEUROLOGY · CLINICAL PRACTICE

Daily Caffeinated Coffee Intake Linked to Reduced Dementia Risk

Daily consumption of 2-3 cups of caffeinated coffee is strongly associated with a dramatically lower long-term risk of dementia and better cognitive function, independently of genetic predisposition. Dementia currently lacks effective preventative pharmacological interventions, making lifestyle modifications a cornerstone of risk reduction strategies.

3/5 Observational

Evidence Meter · 3/5

Real-World Observation

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

1 min readScienceDailyNov 12, 2026

NEUROLOGY · CLINICAL PRACTICE

Clinical Reasoning: A 33-Year-Old Man With Rapidly Progressive Ataxia

Mystery Illness: A Young Man's Fight Against Rapidly Worsening Brain Trouble. Diagnosing brain and nerve problems in patients with weakened immune systems is incredibly complex.

3/5 Observational

Evidence Meter · 3/5

Real-World Observation

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

1 min readNeurologyNov 15, 2026

NEUROLOGY · CLINICAL PRACTICE

Pearls & Oy-sters: Anti-GABA A Receptor Encephalitis Presenting as Fulminant Hemicerebellitis in a 5-Year-Old Girl

This case highlights fulminant cerebellitis as a life-threatening presentation of anti-GABA A R encephalitis and underscores the... She later stabilized with radiographic improvement and meaningful neurologic recovery.

2/5 Preclinical

Evidence Meter · 2/5

Animal & Preclinical Data

Demonstrated in living animal models before large-scale human safety and dosing trials begin.

1 min readNeurologyNov 15, 2026

NEUROLOGY · CLINICAL PRACTICE

Clinical Reasoning: A 60-Year-Old Woman With Progressive Dysarthric Speech and Gait Instability

Readers will navigate a stepwise clinical reasoning approach to subacute cerebellar ataxia, which illustrates the importance of recognizing systemic red flags and monitoring phenotypic evolution as well as how specialized testing based on positive TBA results can resolve diagnostic dilemmas when commercial assays remain unrevealing. Specialized testing in a neuroimmunology laboratory ultimately revealed the diagnosis.

3/5 Observational

Evidence Meter · 3/5

Real-World Observation

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

1 min readNeurologyNov 15, 2026

NEUROLOGY · CLINICAL PRACTICE

Pearls & Oy-sters: Beyond the Bone Marrow-VEXAS Syndrome Presenting as Subacute Encephalomyelitis

Follow-up MRI performed 1 month after presentation showed resolution of contrast enhancement and partial disappearance of spinal T2 hyperintense lesions. Negative infectious PCR testing and the absence of aquaporin 4 and myelin oligodendrocyte glycoprotein antibodies argued against infection or other inflammatory demyelinating condition.

3/5 Observational

Evidence Meter · 3/5

Real-World Observation

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

1 min readNeurologyNov 15, 2026

NEUROLOGY · CLINICAL PRACTICE

Establishing Potosi Virus as a Human Pathogen: Fatal Neuroinvasive Disease in a B-Cell-Depleted Patient

Potosi virus can cause fatal neuroinvasive disease in humans, as evidenced by convergent postmortem neuropathologic, molecular, and ultrastructural evidence. Chronic B-cell depletion may increase susceptibility to severe disease with arboviral infections, which may present without conventional CNS inflammatory markers.

3/5 Observational

Evidence Meter · 3/5

Real-World Observation

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

1 min readNeurologyNov 15, 2026

NEUROLOGY · PRECLINICAL

Placental Clues to Autism's Sex Bias

Placental health and inflammation during pregnancy may play a critical, sex-specific role in autism development. This finding offers a potential explanation for the higher prevalence of autism spectrum disorder diagnoses in boys compared to girls.

2/5 Preclinical

Evidence Meter · 2/5

Animal & Preclinical Data

Demonstrated in living animal models before large-scale human safety and dosing trials begin.

1 min readScienceDailyNov 12, 2026

NEUROLOGY · REAL-WORLD COHORT

Dual-Action Drug Shows Promise Against Alzheimer's DNA Damage and Inflammation

An existing experimental drug shows potential in Alzheimer's by repairing DNA damage and reducing brain inflammation, possibly accelerating new treatment development. The drug's prior successful human safety testing for spinal cord injuries is a significant advantage, potentially expediting its clinical development.

3/5 Observational

Evidence Meter · 3/5

Real-World Observation

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

1 min readScienceDailyNov 12, 2026

NEUROLOGY · CLINICAL PRACTICE

Identification of RIMKLA-IgG Paraneoplastic Neurological Syndrome With Cerebellar Ataxia

In this case series, novel PNS autoantibodies targeting the neural protein RIMKLA were identified in patients with small cell lung cancer and cerebellar ataxia. RIMKLA-IgG represents a new diagnostic biomarker (measurable biological signal) for an intracellular-antigen PNS associated with cerebellar and hindbrain encephalitis with possible peripheral and motor involvement.

4/5 Strong Trial

Evidence Meter · 4/5

Strong Clinical Evidence

Tested directly in patients through a prospective clinical trial or large multicenter human cohort.

1 min readJAMA NeurologyNov 9, 2026

NEUROLOGY · REAL-WORLD COHORT

Dysregulated CSF T-cell responses and their evolution after intravenous immunoglobulin in Guillain-Barré syndrome

Integrated single-cell transcriptomic and TCR analyses provide insight into the early immune response in GBS and identify candidate cellular pathways for biomarker (measurable biological signal) development and therapeutic investigation. Among clonotypes detected in both blood and CSF, CD4+ and tumor-fighting immune cells (CD8+ T cells) exhibited more activated transcriptional states in the CSF, a shift that was particularly pronounced in GBS.

3/5 Observational

Evidence Meter · 3/5

Real-World Observation

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

1 min readBrain: A Journal of NeurologyNov 5, 2026

NEUROLOGY · REAL-WORLD COHORT

Cerebrospinal Fluid Cytokine Expression and Relationships With Neurological Measures in Virologically Controlled People With HIV

Elevated expression of several cytokines in the CSF of virologically suppressed PWH indicates persistent immune activity and supports the existence of a central nervous system (CNS) reservoir. Numerous cytokines showed favorable associations with NP data, including "proinflammatory" cytokines such as IL-6 and TNF-α and several chemotactic cytokines, whereas some "anti-inflammatory" cytokines such as IL-10 correlated positively with unfavorable neurodegenerative markers.

3/5 Observational

Evidence Meter · 3/5

Real-World Observation

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

1 min readAnnals of NeurologyOct 31, 2026

NEUROLOGY · PRECLINICAL

The TBK1-OTUB2-IRF3 signalling complex promotes neuroinflammation and neurodegeneration

This study establishes OTUB2 as a critical regulator of cGAS-STING signalling and a potential therapeutic target for neuroinflammation and neurodegeneration. Additionally, OTUB2 functioned as a scaffold facilitating assembly of the TBK1-interferon (an immune-signaling protein) regulatory factor 3 (IRF3) signalling complex, a prerequisite for IRF3 phosphorylation, and enhanced IRF3 dimerization by reducing its K11 ubiquitination.

2/5 Preclinical

Evidence Meter · 2/5

Animal & Preclinical Data

Demonstrated in living animal models before large-scale human safety and dosing trials begin.

1 min readBrain: A Journal of NeurologyOct 29, 2026

Showing 12 of 13 medical briefings

Interactive Fact Check